Skip to content

A Randomized Double-blind Controlled Study of Sequential Treatment of Traditional Chinese Medicine for Bronchodilatation Secondary to MDR-PA Colonization

Evidence-Based Evaluation of Sangbaipi Decoction Sequential Baozhen Decoction in the Treatment of Bronchodilatation Secondary to MDR-PA Colonization

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000003365
Enrollment
Unknown
Registered
2020-06-02
Start date
2020-06-30
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchiectasis

Interventions

Sponsors

Longhua Hospital Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Test 1: Sang Baipi Decoction loaded with azithromycin in the treatment of bronchiectasis phlegm heat accumulation lung syndrome clinical study 1. Patients who meet the diagnostic criteria for bronchiectasis; 2. It meets the diagnostic criteria of traditional Chinese medicine for phlegm-heat accumulation lung syndrome; 3. The age range is between 18-70 years old; 4. Voluntarily accept the treatment plan and sign an informed consent form. Trial 2: Clinical Study of Baozhen Decoction for Sequential Treatment of Bronchodilator Qi and Yin Deficiency Syndrome 1. Complete the trial 1 Sang Baipi Tang interventional treatment and meet the two syndromes of qi and yin deficiency, Or it has not been treated with traditional Chinese medicine but meets the diagnostic criteria for qi and yin deficiency syndrome; 2. The age range is between 18-70 years old; 3. Voluntarily accept the treatment plan and sign an informed consent form.

Exclusion criteria

Exclusion criteria: Test 1: Sang Baipi Decoction loaded with azithromycin in the treatment of bronchiectasis phlegm heat accumulation lung syndrome clinical study 1. Known allergy to Chinese medicine or azithromycin; 2. Secondary or primary liver and kidney damage is not cured; 3. Patients with diabetes or severe primary diseases such as cardiovascular and cerebrovascular, kidney, lung, and hematopoietic systems; 4. Those with severe cardiopulmonary insufficiency; 5. Patients who are pregnant or lactating; 6. Those with a history of mental illness that is difficult to control; 7. Those who cannot take traditional Chinese medicine due to diseases such as fasting due to gastrointestinal bleeding Trial 2: Clinical Study of Baozhen Decoction for Sequential Treatment of Bronchodilator Qi and Yin Deficiency Syndrome 1. Those who are known to be allergic to traditional Chinese medicine; 2. Secondary or primary liver and kidney damage is not cured; 3. Patients with diabetes or severe primary diseases such as cardiovascular and cerebrovascular, kidney, lung, and hematopoietic systems; 4. Those with severe cardiopulmonary insufficiency; 5. Patients who are pregnant or lactating; 6. Those with a history of mental illness that is difficult to control; 7. Those who cannot take traditional Chinese medicine due to diseases such as fasting due to gastrointestinal bleeding

Design outcomes

Primary

MeasureTime frame
Chest CT;TCM syndrome points;Sputum bacteria conversion rate;

Secondary

MeasureTime frame
Number of acute exacerbations;Lung function;

Countries

China

Contacts

Public ContactWu Dingzhong

Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

wdz06@sohu.com+86 021-64385700-2320

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026